Molecular Carcinogenesis · 2019 · 26 citations · 21 references
Life SciencesMolecular BiologyOncologyApoptosisMolecular OncologySignal TransductionCancer Cell SignalingCancer Molecular PathologyCancer ProgressionCancer TranscriptomicsOncogenic ProliferationOncogenic Signaling PathwaysCancer Cell Proliferation InhibitionCell Proliferation IndicesMyc ActivationMyc In Lung CancerMyc In Tumor ProgressionOncogenic Myc SignalingOncogenic TransformationTissue Growth Regulation
Carboxypeptidase A4 (CPA4) is a member of the metallocarboxypeptidase family. A previous study indicated that CPA4 may participate in the modulation of peptide hormone activity and hormone-regulated tissue growth and differentiation. However, the role of CPA4 in lung tumorigenesis remains unclear. Our study revealed that CPA4 expression was higher in both lung cancer cells and tumor tissues. We performed 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide assays, colony-formation assays, and Cellomics ArrayScan Infinity analysis to demonstrate that CPA4 knockdown inhibited non small-cell lung cancer (NSCLC) cell proliferation. Conversely, ectopic expression of CPA4 enhanced lung cancer cell proliferation. Consistent with these observations, we generated xenograft tumor models to confirm that CPA4 downregulation suppressed NSCLC cell growth. Mechanistically, we revealed that CPA4 downregulation may induce apoptosis and G1-S arrest by suppressing the protein kinase B/c-MYC pathway. These results suggest that CPA4 has an oncogenic effect on lung cancer growth. Taken together, we identified a novel gene in lung cancer that might provide a basis for new therapeutic targets.
21
Bcl-2 is an apoptotic target suppressed by both c-Myc and E2F-1
Christine M. Eischen, Graham Packham, John Nip et al. · Oncogene · 2001 · 168 citations
Genomewide Scan for Prostate Cancer–Aggressiveness Loci
John S. Witte, Katrina A.B. Goddard, David V. Conti et al. · The American Journal of Human Genetics · 2000 · 159 citations · Full text